T. Hashiguchi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
T Hashiguchi, T. Hashiguchi, Takao Hashiguchi
Publication record
88 papers · 3,181 citations · H-index 28

PAPERS

Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
20241 citationsauthor #13
Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus
202311 citationsauthor #17
Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus
202322 citationsauthor #6
Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein
20235 citationsauthor #6
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
202319 citationsauthor #21
Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants
20238 citationsauthor #6
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
20237 citationsauthor #9
Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
20237 citationsauthor #36
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
2023281 citationsauthor #37
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
202219 citationsauthor #3
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
2022219 citationsauthor #38
Germinal center-derived broadly neutralizing antibodies adapt to SARS-CoV-2 antigenic drift
20220 citationsauthor #5
Assessing the zoonotic potential of a novel bat morbillivirus
20221 citationsauthor #17
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
2022157 citationsauthor #42
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants
202212 citationsauthor #20
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
202251 citationsauthor #34
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
20229 citationsauthor #22
CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis
202116 citationsauthor #6
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
202152 citationsauthor #33
Zoonotic potential of a novel bat morbillivirus
202112 citationsauthor #16
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
2021151 citationsauthor #21
Characterization of Natural and Synthetic Sialoglycans Targeting the Hemagglutinin-Neuraminidase of Mumps Virus
20210 citationsauthor #7
The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection
202110 citationsauthor #6
Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193
20210 citationsauthor #15
Unique Tropism and Entry Mechanism of Mumps Virus
20219 citationsauthor #2
Viral Biophysics: Contributions to Drug Modalities
20210 citationsauthor #3
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
202138 citationsauthor #4
Preparation of glycopolymers having sialyl α2→3 lactose moieties as the potent inhibitors for mumps virus.
202110 citationsauthor #5
Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable Site
20210 citationsauthor #30
Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin
202110 citationsauthor #3
Lysosome-Associated Membrane Proteins Support the Furin-Mediated Processing of the Mumps Virus Fusion Protein
202014 citationsauthor #5
Identification of Anti-COVID-19 Agents, Cepharanthine and Nelfinavir, and Their Potential Usage for Combination Treatment
20201 citationsauthor #22
Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase
202021 citationsauthor #7
Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes
202024 citationsauthor #2
Large-Scale Expression and Purification of Mumps Virus Hemagglutinin-Neuraminidase for Structural Analyses and Glycan-Binding Assays.
20202 citationsauthor #2
New Insights into Measles Virus Brain Infections.
201954 citationsauthor #4
Disruption of the Dimer-Dimer Interaction of the Mumps Virus Attachment Protein Head Domain, Aided by an Anion Located at the Interface, Compromises Membrane Fusion Triggering
20195 citationsauthor #7
Crystal structure of Mumps virus hemagglutinin-neuraminidase bound to sialyl lewisX
20190 citationsauthor #6
Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species
201920 citationsauthor #8
Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates
20199 citationsauthor #2
Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus
201924 citationsauthor #6
Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route
201927 citationsauthor #13
Crystal structure of Mumps virus hemagglutinin-neuraminidase bound to the oligosaccharide portion of the GM2 ganglioside
20190 citationsauthor #6
Biophysical characterization and single‐chain Fv construction of a neutralizing antibody to measles virus
20199 citationsauthor #11
Structures of the prefusion form of measles virus fusion protein in complex with inhibitors
201869 citationsauthor #1
Annexin A2 Mediates the Localization of Measles Virus Matrix Protein at the Plasma Membrane
201824 citationsauthor #3
Crystal structure of the prefusion form of measles virus fusion protein
20180 citationsauthor #1
Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein
201842 citationsauthor #4
Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain
201833 citationsauthor #12
Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein.
20176 citationsauthor #4
[Molecular basis for negative-strand RNA virus entry and neutralization by antibodies].
20170 citationsauthor #1
Crystal structure of Mumps virus hemagglutinin-neuraminidase
20160 citationsauthor #14
Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus
201695 citationsauthor #16
Crystal structure of Mumps virus hemagglutinin-neuraminidase bound to 3-sialyllactose
20160 citationsauthor #14
The Molecular Tool‐Kit of Viral Hemorrhagic Fevers
20150 citationsauthor #5
Mechanism of human antibody-mediated neutralization of Marburg virus.
2015146 citationsauthor #7
Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78
20150 citationsauthor #1
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
201545 citationsauthor #3
Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
20153 citationsauthor #2
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
201545 citationsauthor #2
Structural basis for Marburg virus neutralization by a cross-reactive human antibody.
2015134 citationsauthor #1
Mutations in the Putative Dimer-Dimer Interfaces of the Measles Virus Hemagglutinin Head Domain Affect Membrane Fusion Triggering*
201315 citationsauthor #3
Structure of an Ebola Virus-Protective Antibody in Complex with its Mucin-Domain Linear Epitope.
20123 citationsauthor #5
[Structural basis for measles virus-receptor recognition and its functional implications for viral entry and vaccination].
20120 citationsauthor #2
Structural Basis for Differential Neutralization of Ebolaviruses
201272 citationsauthor #4
Crystallization strategy for the glycoprotein-receptor complex between measles virus hemagglutinin and its cellular receptor SLAM.
20121 citationsauthor #1
Measles Virus Hemagglutinin: Structural Insights into Cell Entry and Measles Vaccine
201157 citationsauthor #1
Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus
201151 citationsauthor #5
Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM
2011235 citationsauthor #1
Crystal structure of the measles virus hemagglutinin bound to its cellular receptor SLAM (Form I)
20110 citationsauthor #1
Crystal structure of the measles virus hemagglutinin bound to its cellular receptor SLAM (Form I, MV-H-SLAM(N102H/R108Y) fusion)
20110 citationsauthor #1
Measles virus receptors.
200993 citationsauthor #4
Recent progress in measles virus research
20090 citationsauthor #3
Measles Virus Infects both Polarized Epithelial and Immune Cells by Using Distinctive Receptor-Binding Sites on Its Hemagglutinin
2008110 citationsauthor #4
Dynamic Interaction of the Measles Virus Hemagglutinin with Its Receptor Signaling Lymphocytic Activation Molecule (SLAM, CD150)*
200876 citationsauthor #6
Homogeneous sugar modification improves crystallization of measles virus hemagglutinin.
20084 citationsauthor #1
X-ray crystallographic analysis of measles virus hemagglutinin.
20085 citationsauthor #1
Measles virus infects both polarized epithelial and immune cells using 3 distinctive receptor-binding sites on its hemagglutinin 4 5
20082 citationsauthor #4
CD 46-Independent Mechanism and Syncytium Formation via a SLAM-and Supports Efficient Measles Virus Growth A Human Lung Carcinoma Cell Line
20070 citationsauthor #8
A Human Lung Carcinoma Cell Line Supports Efficient Measles Virus Growth and Syncytium Formation via a SLAM- and CD46-Independent Mechanism
200791 citationsauthor #3
Crystal structure of measles virus hemagglutinin provides insight into effective vaccines
2007237 citationsauthor #1
Crystal structure of the measles virus hemagglutinin (complex-sugar-type)
20072 citationsauthor #1
Tal1/Scl Gene Transduction Using a Lentiviral Vector Stimulates Highly Efficient Hematopoietic Cell Differentiation from Common Marmoset (Callithrix jacchus) Embryonic Stem Cells
200629 citationsauthor #9
Multiple Amino Acid Substitutions in Hemagglutinin Are Necessary for Wild-Type MeaslesVirus To Acquire the Ability To Use Receptor CD46 Efficiently
200665 citationsauthor #4
Generation of Measles Virus with a Segmented RNA Genome
200640 citationsauthor #6
Analysis and Identification of Serological Tumor Antigens in Patients Treated with the GM-CSF-Gene Transduced-Autologous Tumor Vaccines (GVAX®) for Renal Cell Carcinoma.
20040 citationsauthor #2
Hematopoietic Cell Differentiation from Common Marmoset (Callithrix jacchus) Embryonic Stem Cells by Their Genetic Manipulation Using the Third Generation Lentiviral Vector.
20043 citationsauthor #10
582. Detection of enhanced serum antibody production to renal cell cancer proteins and identification of serological tumor antigens in patients treated with the GM-CSF-gene transduced-autologous tumor vaccines (GVAX|[reg]|)
20040 citationsauthor #1

TIMELINE

2004 3 citations

2006 134 citations

2007 330 citations

2008 197 citations

2009 93 citations

2011 343 citations

2012 76 citations

2013 15 citations

2015 328 citations

2016 95 citations

2017 6 citations

2018 168 citations

2019 148 citations

2020 62 citations

2021 308 citations

2022 468 citations

2023 360 citations

2024 1 citations

COAUTHOR MAP

CONCEPT FOOTPRINT